secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axogen, Inc. (AXGN)
CIK:        0000805928
Form:       8-K
Filed at:   2022-08-03T23:59:59+00:00
Accession:  0000805928-22-000100
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Axogen Q2 revenue $34.5M (+3% YoY); adjusted net loss narrows to $2.6M; reaffirms FY2022 guidance
--------------------------------------------------------------------------------

- Net revenue $34.5M, +3% YoY; ex-Avive (suspended June 2021) revenue grew 9%.
- Gross margin 81.8% vs 78.9% in Q2 2021 (included $1.4M Avive write-down).
- Adjusted net loss $2.6M ($0.06/share) vs loss $3.7M ($0.09/share) in Q2 2021.
- Cash+investments $64.3M, down from $73.7M at March 2022; $3.9M capex for Dayton facility.
- FY2022 revenue guidance reaffirmed at $135-142M; gross margin expected above 80%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/805928/000080592822000100/0000805928-22-000100-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/805928/000080592822000100/axgn-20220803.htm
  HTML page:      https://secwatch.observer/filing/0000805928-22-000100

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer